ArticleFrontiers in aging neuroscience2025
Character-level linguistic biomarkers for precision assessment of cognitive decline: a symbolic recurrence approach.
Article in Frontiers in aging neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- A 60-second interpretable voice model for early dementia screening.PLOS digital health · 2026Article
- CharMark: character-level Markov modeling for interpretable linguistic biomarkers of cognitive decline.Frontiers in digital health · 2025Article
- Character-level linguistic biomarkers for precision assessment of cognitive decline: a symbolic recurrence approach.Frontiers in aging neuroscience · 2025Article
- A transparent four-feature speech model for depression screening applicable across clinical and community settings, including assisted-living environments.Frontiers in digital health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Early-stage Alzheimer's disease (AD) remains difficult to assess using conventional linguistic or cognitive assessments, which often overlook subtle and individualized disruptions in speech. In this work, we propose a novel biomarker discovery framework that leverages fine-grained, character-level information from speech transcripts to capture these early cognitive changes. By encoding transcripts symbolically at the character level and applying recurrence quantification analysis (RQA), we generate interpretable recurrence plots that reveal temporal dynamics in speech patterns such as pauses, repetitions, and hesitations. Siamese neural networks are then used to learn embeddings from these recurrence representations, enabling the discovery of discriminative linguistic biomarkers associated with cognitive decline. Applied to the DementiaBank corpus, our approach uncovers meaningful character-level signatures and enables visualization of subtle cognitive disruptions through recurrence plots. These findings suggest that character-level temporal patterns may offer a promising new direction for digital biomarker discovery in dementia research, complementing traditional word-level analyses and enhancing interpretability for clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.